
PUBLICATIONS (Books , Book Chapters and Reviews)
In addition to original research papers, staff from the School's research groups contribute a wide range of books, book chapters and invited review articles to the scientific literature. In order to provide a 'flavour' of the breadth of research activities within the groups, a selection of books, chapters and reviews are listed on this page.
Individual original research papers published by our staff can be accessed by searching in bibliographic databases such as 'Web of Science'.
DRUG DELIVERY AND BIOMATERIALS RESEARCH GROUP
Gorman SP, Tunney MM, Jones DS (2007) Biofilms as a cause of infection in hospital environments. Chapter in: Handbook of cosmetic and drug microbiology. Ed. Orth DS, Kabara JJ, Denyer SP, Tan SK. Marcel Dekker (in press)
Hamill TM, Gilmore BF, Jones DS, Gorman SP (2007) Strategies for the Development of the Urethral Catheter. Expert Rev Med Devices. 4: 215-225
McCoy CP, Donnelly, L, Edwards CR, Gray C, Rooney GAK (2007) Triggered drug release from medical polymers, GAK Gummi Fasern Kunststoffe, 158-163
Malcolm RK, McCullough, SD, Morrow RJ, Woolfson AD (2006) Vagina and uterus as drug-absorbing organs. In: Enhancement in Drug Delivery (Eds. Barry, B.W., Touitou, E.) Taylor and Francis, New York, pp 395-439
Donnelly RF, Juzenas P, McCarron PA, Woolfson AD, Moan J (2006) Drug delivery for topical photodynamic therapy: difficulties and novel solutions. Trends in Cancer Research 2:1-20
Woolfson AD, Malcolm RK, Morrow RJ, Toner CF, Lowry D, Jamil A, McCullagh SD (2006) Potential use of vaginal rings for prevention of heterosexual transmission of HIV. American J. Drug Del. 4. 7-20
McCoy CP, Donnelly, L, Edwards CR, (2006) Triggered release of therapeutics from medical polymers. In: Medical Polymers 2006 Smithers. Rapra, Shrewsbury, UK. Ch. 23, pp 1-8
Donnelly RF, McCarron PA, Woolfson AD (2005) Drug Delivery of Aminolevulinic acid from Topical Formulations Intended for Photodynamic Therapy. Photochemistry and Photobiology. 81: 750-767
Donnelly RF, McCarron PA, Andrews GP, Woolfson AD (2005) Excipient-excipoent interactions in pharmaceutical systems intended for topical administration. Pharm Tech Europe, pp 1-6
Gorman SP, Jones DS (2005) Medical device composition and biological secretion influences on biofilm formation. Chapter 4 in: Biofilm Infections, roles of antibiotic tolerance and resistance. Ed. Pace J, Rupp M, Finch R. Marcel Dekker, NY pp 51-70
Parsons C, Jones DS, Gorman SP (2005) The Intraocular Lens: Challenges in the prevention and therapy of infectious endophthalmitis and posterior capsular opacification. Expert Review of Medical Devices 2: 161-175
Kett VL, McMahon D, Ward K (2005) Thermoanalytical techniques for the investigation of the freeze drying process and freeze-dried products. Current Pharmaceutical Biotechnology 6: 239-250
Kett VL, McMahon D, Ward K (2004) Freeze-drying of protein pharmaceuticals - The application of thermal analysis. Cryoletters 25: 389-404
Malcolm, RK, Woolfson, AD, Toner C and Lowry D (2004) Vaginal microbicides for the prevention of HIV transmission. Biotechnology and Genetic Engineering Reviews 21: 81-121
McCarron PA, Hall M (2004) Pharmaceutical nanotechnology. In: Encyclopedia of nanoscience and nanotechnology, Volume 8: Ed: Nalwa HS. American Scientific Publishers, NY. pp 469-487
Scott EM, Gorman SP (2004) Chemical disinfectants, antiseptics and preservatives. Chapter 17 in: Pharmaceutical Microbiology 7th Edition, eds. Denyer SP, Hodges N, Gorman SP. Blackwell Scientific Publications. pp 285-305
Malcolm K, Toner C (2003) Drug delivery - HIV microbicides Chemistry & Industry 5: 23-24
Gorman SP, Jones DS (2003) Complications of urinary devices. Chapter in: Medical Implications of Biofilms ed. Wilson M. Cambridge University Press. pp 136-170
McCrory R, Jones DS, Gorman SP, Adair CG (2003) Pharmaceutical strategies to prevent ventilator-associated pneumonia. Journal of Pharmacy & Pharmacology 55: 411-428
Woolfson AD (2002) Intravaginal drug delivery technologies. In: Modified-release Drug Delivery Technology. (Eds. Rathbone MJ, Hadgraft J) Marcel Dekker, New York. pp 759-774
Malcolm RK, Woolfson AD (2002) Blocking heterosexual transmission of HIV: intravaginal rings for the controlled delivery of topical microbicides. Drug Delivery Systems and Sciences. 1: 117-121
Gorman SP, Jones DS (2002) Antimicrobial biomaterials for medical devices. World Markets Research Centre, Medical Device Manufacturing and Technology, pp 97–101
Scott EM, Gorman SP (2001) Glutaraldehyde Sterilisation. Chapter in: Disinfection, Sterilisation and Preservation. 5th Edition, ed. Block SS, Lippincott Williams & Wilkins, Philadelphia, pp 61-88
Woolfson AD, Malcolm RK, McCarron PA, Jones, DS (2001) Bioadhesive Drug Delivery Systems. In: Polymeric Biomaterials 2nd edn. (Ed. Dumitriu S) Marcel Dekker, New York, pp.1063-1082
CLINICAL AND PRACTICE RESEARCH GROUP
Hughes CM (2007) Preventing adverse drug events in nursing home residents.Aging Health 3: 15-22
Hughes CM, Smith MBH, Tunney MM (2007) Infection control strategies for preventing the transmission of methicillin-resistant Staphylococcus aureus in nursing homes and associated older residents.(Protocol). Cochrane Database of Systematic Reviews, Issue 1
Hughes CM, Lapane KL, Watson MC, Davies HTO (2007) Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs and Aging 24: 81-93
Hanlon JT, Sschmader KE, Hughes CM, Lapane KL, Swine C, Spinewine A (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? The Lancet, in press
Hughes CM, Bleakley C (2006) Treatment of knee pain in primary care. Pharmacists and physiotherapists need to be part of the team. BMJ 333: 981-982
Hughes CM, Lapane KL (2005) Administrative initiatives to reduce inappropriate prescribing of psychotropics in nursing homes: how successful have they been? Drugs and Aging 22: 339-351
McElnay JC and Chaw S (2005) Pharmacokinetics in neonates. In: Paediatric clinical research manual. Eds: P. Helms and P. Stonier. Euromed Communications Ltd.
McAlister DA, Hughes CM, Fleming I, O’Neill C. (2005) Costs of pharmacological care of the elderly. Reviews in Clinical Gerontology 14: 71-78
Hughes CM (2004) Medication non-adherence in the elderly: how big is the problem? Drugs and Aging 21: 793-811
McElnay JC, Hughes CM (2003) Alternative medicines and the elderly. In: Cherniack P, Cherniack N (Eds). Alternative Medicine for the Elderly. Springer-Verlag, Berlin, Heidelberg, New York. pp 47-61
Hughes CM (2003) Monitoring self-medication. Expert Opinion on Drug Safety 2: 1-5
Crealey GE, Sturgess IK, McElnay JC, Hughes CM (2003) Pharmaceutical care programmes for the elderly: economic issues. Pharmacoeconomics 21: 455-465
Fleming GF, McElnay JC, Hughes CM (2003) Drug misuse in Northern Ireland: the role of the community pharmacist. In: Drug misuse and community pharmacy. Eds. Sheridan J, Strang J. Taylor and Francis, London/New York. pp 63-72
Hughes CM, Patterson S, Schweizer AK (2003) Information is care: the need for data to assess the quality of care in UK nursing and residential homes. Expert Opinion in Drug Safety 2: 523-527
Crealey GE, Sturgess IK, McElnay JC and Hughes CM (2003) Pharmaceutical care programmes for the elderly. Economic issues.Pharmacoeconomics 21: 455-465
Lapane KL, Hughes CM (2002) Optimizing drug utilization in long-term care: The case of coronary heart disease. Pharmacoeconomics 20: 143-152
Hughes CM, Lapane KL (2002) The drive for quality care in US nursing homes in the era of the Prospective Payment System. Drugs and Aging 19: 623-631
McElnay JC, Hughes CM (2002) Drug delivery: buccal absorption. In: The encyclopedia of pharmaceutical technology. Eds. Swarbrick J, Boylan JC, Marcel Dekker Inc., New York. pp 800-810
Fleming GF, McElnay JC, Hughes CM (2002) Drug misuse in Northern Ireland: the role of the community pharmacist. In: Drug Misuse and Community Pharmacy. Ed. Sheridan J, Strang J. Taylor and Francis, London. pp 63-72
Hughes CM (2001) Drug use in nursing homes: legislating for quality. Geriatrics and Aging 4: 8-11
Hughes CM, McElnay JC, Fleming GF (2001) Risks and benefits of self-medication. Drug Safety 24: 1027-1037
EXPERIMENTAL THERAPEUTICS RESEARCH GROUP
Hirst DG (2007) The Importance of Radiobiology to Cancer Therapy: Current Practice and Future Perspectives. Clin Oncol (R Coll Radiol). Apr 20; [Epub ahead of print]
Hirst DG, Robson T (2007) Nitrosative stress in cancer therapy. Front Biosci. 12: 3406-18
Hirst DG, Robson T (2007) Targeting nitric oxide for cancer therapy. J. Pharm. Pharmacol. 59: 3-13
Robson T, Worthington J, McKeown SR, Hirst DG (2005) Radiogenic therapy: novel approaches for enhancing tumour radiosenstivity. Technol. Cancer Res. Treat. 4: 343-62
McKeown SR, Ward C, Robson T (2004) Gene directed enzyme prodrug therapy (GDEPT) - a current assessment. Current Opinions in Molecular Therapeutics 6. 4: 421-435
Robson T, Hirst DG (2003) Transcriptional targeting in cancer gene therapy. J. Biomed. Biotechnol. 2: 110-137
Walker MD, Lowe AS, Nicholson D, Kennovin GD, Hirst DG (2003) Delayed wound healing in mouse skin following irradiation. In Chronic Irradiation: Tolerance and Failure in Complex Biological Systems. Br. J. Radiol. Supplement 26; Eds. Fliedner TM, Feinendegen LE, Hopewell JW, pp 164-169
BIOMOLECULAR SCIENCE RESEARCH GROUP
Paunovic V, Carroll HP, Vandenbroeck K, Gadina M (2007) The many roles of cytokines in autoimmunity: no longer “all in the family”. Rheumatology. In Press April 2007
O´Doherty C, Villoslada P, Vandenbroeck K. Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes. (2007) Cytokine & Growth Factor Rev. In Press April 2007
Olwill S, Buick RJ, Scott, CJ (2007) Antibody Conjugates Promise to Deliver. Euro Biopharm Rev, Spring, 44-47
Vandenbroeck K, Goris A (2006) The IFNG–IL26–IL22 gene cluster of cytokines. In: Cytokine Gene Polymorphisms in Multifactorial Conditions (Ed. Vandenbroeck K), CRC Press, pp 157–174
Quinn D, Buick R, Scott CJ (2006) Mapping the Interactome - Technologies for the discovery of novelprotein-protein interactions. Euro Biopharm Rev., Spring, 66-70
Vandenbroeck, K. (Ed). (2006) ‘Cytokine Gene Polymorphisms in Multifactorial Conditions’, ISBN: 0849336198, Taylor and Francis, CRC Press, Boca Raton, Florida, USA
McCarron PA, Olwill SA, Marouf WM, Buick RJ, Walker B, Scott CJ (2005) Antibody Conjugates and Therapeutic Strategies. Molecular Interventions. 5: 70-382
Vandenbroeck K, Alloza I, Gadina M, Matthys P (2004) Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges. J. Pharm. Pharmacol. 56: 145–160
Buick R, Scott CJ (2004) Protein Antigens for Therapeutic and Diagnostic Antibodies. Euro Biopharm Rev., Spring 2004, 78-81
Vandenbroeck K, Goris A (2003) Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy? Trends Pharmacol. Sci. 24: 284–289
Kushner T, Shaw C (2002). Chris Shaw on ethical issues in biotechnology.Cambridge Quarterly Of Healthcare Ethics 11: 97-101
Walker B, Lynas JF (2001) Strategies for the inhibition of serine proteases. Cellular and Molecular Life Sciences 58: 596-624